Kidney complications of parasitic diseases.
Journal
Nature reviews. Nephrology
ISSN: 1759-507X
Titre abrégé: Nat Rev Nephrol
Pays: England
ID NLM: 101500081
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
accepted:
25
02
2022
pubmed:
30
3
2022
medline:
25
5
2022
entrez:
29
3
2022
Statut:
ppublish
Résumé
Parasitic agents have been known to cause human disease since ancient times and are endemic in tropical and subtropical regions. Complications of parasitic diseases, including kidney involvement, are associated with worse outcomes. Chagas disease, filariasis, leishmaniasis, malaria and schistosomiasis are important parasitic diseases that can damage the kidney. These diseases affect millions of people worldwide, primarily in Africa, Asia and Latin America, and kidney involvement is associated with increased mortality. The most common kidney complications of parasitic diseases are acute kidney injury, glomerulonephritis and tubular dysfunction. The mechanisms that underlie parasitic disease-associated kidney injury include direct parasite damage; immunological phenomena, including immune complex deposition and inflammation; and systemic manifestations such as haemolysis, haemorrhage and rhabdomyolysis. In addition, use of nephrotoxic drugs to treat parasitic infections is associated with acute kidney injury. Early diagnosis of kidney involvement and adequate management is crucial to prevent progression of kidney disease and optimize patient recovery.
Identifiants
pubmed: 35347315
doi: 10.1038/s41581-022-00558-z
pii: 10.1038/s41581-022-00558-z
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
396-406Informations de copyright
© 2022. Springer Nature Limited.
Références
World Health Organization. Control of neglected tropical diseases. https://www.who.int/teams/control-of-neglected-tropical-diseases (2021).
World Health Organization. Malaria. Key Facts https://www.who.int/news-room/fact-sheets/detail/malaria (2022).
Souza et al. Infectious and parasitic diseases in Brazil, 2010 to 2017: considerations for surveillance. Rev. Panam. Salud Publica 44, e10 (2020).
pubmed: 32051684
pmcid: 7008608
Goterris, L. et al. Screening of parasitic diseases in the asymptomatic immigrant population. Enferm. Infecc. Microbiol. Clin. 34, 25–31 (2016).
pubmed: 27474244
doi: 10.1016/S0213-005X(16)30216-6
Berto, C. G., Coyle, C. M., Friedman, L. & Walker, P. F. Where was my patient born? The intersection of tropical medicine and migrant health. Curr. Opin. Infect. Dis. https://doi.org/10.1097/QCO.0000000000000773 (2021).
doi: 10.1097/QCO.0000000000000773
pubmed: 34267044
Buosi, A. P. A. et al. The rights of patients with chronic kidney disease in the world: legal perspectives and challenges in Brazil, India, Portugal, South Africa, and Nigeria. Contrib. Nephrol. 199, 322–338 (2021).
Moura-Neto, J. A., Divino-Filho, J. C. & Ronco, C. Nephrology Worldwide (Springer Nature, 2021).
Srisawat, N. & Sitprija, V. Tropical diseases: a public health problem with impact on nephrology. in Tropical Nephrology (Bezerra da Silva Junior, G., De Francesco Daher, E. & Barros, E.) 1–16 (Springer Nature, 2020).
Meneses, G. C. et al. Novel kidney injury biomarkers in tropical infections: a review of the literature. Rev. Inst. Med. Trop. S. Paulo. 62, e14 (2020).
pubmed: 32074217
pmcid: 7032010
doi: 10.1590/s1678-9946202062014
Daher, E. F., Silva Junior, G. B., Barros, E. & Antunes, V. V. H. Renal involvement in Chagas’ disease (American trypanosomiasis). in Tropical Nephrology (Bezerra da Silva Junior, G. B., De Francesco Daher, E. F. & Barros, E.) 105–112 (Springer Nature, 2020).
World Health Organization. Chagas disease (American trypanosomiasis) — Epidemiology https://www.who.int/chagas/epidemiology/en/#:~:text=An%20estimated%208%20million%20people,10%20000%20deaths%20per%20year . (2020).
Silva Junior, G. B., Antunes, V. V. H., Motta, M., Barros, E. J. G. & Daher, E. F. Chagas disease-associated kidney injury — a review. Nefrol. Latinoam. 14, 22–26 (2017).
doi: 10.1016/j.nefrol.2016.12.001
Bey, E. et al. Lower urinary tract dysfunction in chronic Chagas disease: clinical and urodynamic presentation. World J. Urol. 37, 1395–1402 (2019).
pubmed: 30302592
doi: 10.1007/s00345-018-2512-3
Petruccelli, K. C. et al. Type 1 cardiorenal syndrome in a patient with an acute infection caused by Trypanosoma cruzi in the Brazilian Amazon region — a case report. Rev. Soc. Bras. Med. Trop. 51, 869–872 (2018).
pubmed: 30517546
doi: 10.1590/0037-8682-0156-2018
González, R. P. et al. Incidence, mortality and positive predictive value of type 1 cardiorenal syndrome in acute coronary syndrome. PLoS One 11, e0167166 (2016).
doi: 10.1371/journal.pone.0167166
Fernandes, A. M. S. et al. Malnutrition, anemia and renal dysfunction in patients with Chagasic cardiomyopathy. Int. J. Cardiol. 151, 109–110 (2011).
pubmed: 21719128
doi: 10.1016/j.ijcard.2011.06.019
Lemos, J. R. D. et al. Influence of parasite load on renal function in mice acutely infected with Trypanosoma cruzi. PLoS One 8, e71772 (2013).
pubmed: 23951243
pmcid: 3741127
doi: 10.1371/journal.pone.0071772
Tarleton, R. L. Chagas disease: a role for autoimmunity? Trends Parasitol. 19, 447–451 (2003).
pubmed: 14519582
doi: 10.1016/j.pt.2003.08.008
Shintaku, M., Takeda, S., Miura, S., Yutani, C. & Tsutsumi, Y. Chronic Chagastic cardiomyopathy associated with membranoproliferative glomerulonephritis: report of an autopsy case. Pathol. Int. 70, 47–52 (2020).
pubmed: 31840862
doi: 10.1111/pin.12883
Oliveira, G. M. et al. Absence of Fas-L aggravates renal injury in acute Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz. 104, 1063–1071 (2009).
pubmed: 20140366
doi: 10.1590/S0074-02762009000800002
Oliveira, G. M., Silva, T. M., Batista, W. S., Franco, M. & Schor, N. Acute Trypanosoma cruzi experimental infection induced renal ischemic/reperfusion lesion in mice. Parasitol. Res. 106, 111–120 (2009).
pubmed: 19784671
doi: 10.1007/s00436-009-1637-0
Xavier-Júnior, J. C. C., Silva, V. S. & Viero, R. M. Membranous nephropathy PLA2R+ associated with Chagas disease. Autops. Case Rep. 5, 27–32 (2015).
pubmed: 26558244
pmcid: 4636103
doi: 10.4322/acr.2015.014
Carvalho, M. F., Franco, M. F. & Soares, V. A. Amastigotes forms of Trypanosoma cruzi detected in a renal allograft. Rev. Inst. Med. Trop. S. Paulo 39, 223–226 (1997).
pubmed: 9640786
doi: 10.1590/S0036-46651997000400008
Pierrotti, L. C. et al. Chagas disease recommendations for solid-organ transplant recipients and donors. Transplantation 102, S1–S7 (2018).
pubmed: 29381572
doi: 10.1097/TP.0000000000002019
Silva, A. E. et al. Acute Chagas’ disease in postrenal transplant and treatment with benzonidazole. Ann. Diagn. Pathol. 14, 199–203 (2010).
pubmed: 20471566
doi: 10.1016/j.anndiagpath.2009.06.008
Inga, L. A. C. & Olivera, M. J. Reactivation of Chagas disease in a heart transplant patient infected by sylvatic Trypanosoma cruzi discrete typing unit I. Rev. Soc. Bras. Med. Trop. 52, e20180512 (2019).
pubmed: 31340357
doi: 10.1590/0037-8682-0512-2018
Ferraresso, M. G., Torre, A. C., Piva, M. M. M. & Barcan, L. Chagas disease reactivation: cutaneous manifestations in a transplanted patient. Bras. Dermatol. 93, 890–892 (2018).
Pinheiro, M. E., Duarte, D. B., Oliveira, M. J. C. & Fontes, G. Nephropathy in lymphatic filariasis. in Tropical Nephrology (Bezerra da Silva Junior, G. B., De Francesco Daher, E. F. & Barros, E.) 137–153 (Springer Nature, 2020).
Kapa, D. R. & Mohamed, A. J. Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia. Int. Health 13, S17–S21 (2020).
pubmed: 33349881
pmcid: 7753165
doi: 10.1093/inthealth/ihaa056
World Health Organization. Lymphatic filariasis — epidemiology. https://www.who.int/lymphatic_filariasis/epidemiology/en/ (2020).
Adeleke, A. A. Parasitic chyluria in a 72-year-old Sierra Leonean woman: a case report. Afr. J. Prim. Health Care Fam. Med. 11, e1–e4 (2019).
pubmed: 31714130
doi: 10.4102/phcfm.v11i1.2093
Local Burden of Disease 2019 Neglected Tropical Diseases Collaborators. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis. Lancet Glob. Health 8, e1186–e1194 (2020).
doi: 10.1016/S2214-109X(20)30286-2
Faraj, J., Mander, J., Burnett, J. R. & Prentice, D. Filiarial chyluria with nephrotic-range proteinuria and associated hypoalbuminaemia and hypogammaglobulinaemia secondary to bilateral lymphorenal fistulae. BMJ Case Rep. 2017, bcr2017221114 (2017).
pmcid: 5652507
doi: 10.1136/bcr-2017-221114
van Velthuysen, M. L. F. & Florquin, S. Glomerulopathy associated with parasitic infections. Clin. Microbiol. Rev. 13, 55–66 (2000).
pubmed: 10627491
pmcid: 88933
doi: 10.1128/CMR.13.1.55
Sudrania, M. K., Valson, A. T., Dangi, A. D. & Kekre, N. S. Chyluria with massive proteinuria: do not reach for the biopsy gun! Saudi. J. Kidney Dis. Transpl. 31, 1407–1410 (2020).
doi: 10.4103/1319-2442.308357
Cheng, J. T., Mohan, S., Nasr, S. H. & D’Agati, V. D. Chyluria presenting as milky urine and nephrotic-range proteinuria. Kidney Int. 70, 1518–1522 (2006).
pubmed: 16871246
doi: 10.1038/sj.ki.5001703
Sundar, S., Venkataramanan, K., Verma, H., Bhardwaj, M. & Mahapatra, H. S. Filariasis, with chyluria and nephrotic range proteinuria. J. Assoc. Physicians India 61, 487–489 (2013).
pubmed: 24772754
Shubham, S., Ahuja, A. & Bhardwaj, M. Microfilaria in kidney biopsy: a report of two cases. J. Infect. Public Health 11, 732–734 (2018).
pubmed: 29895474
doi: 10.1016/j.jiph.2018.05.004
Saha, M. et al. An occult filarial infection presenting as chyluria with proteinuria: a case report and review of literature. BMJ Case Rep. 2012, bcr0120125635 (2012).
pubmed: 22669920
pmcid: 4542962
Nayak, H. K. et al. A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy. Clin. Exp. Nephrol. 15, 591–595 (2011).
pubmed: 21519822
doi: 10.1007/s10157-011-0448-7
Date, A., Neela, P. & Shastry, J. C. Membrano proliferative glomerulonephritis in a tropical environment. Ann. Trop. Med. Parasitol. 77, 279–285 (1983).
pubmed: 6625727
doi: 10.1080/00034983.1983.11811708
Burza, S., Croft, S. L. & Boelaert, M. Leishmaniasis. Lancet 392, 951–970 (2018).
pubmed: 30126638
doi: 10.1016/S0140-6736(18)31204-2
Silva Junior, G. B., Barros, E. J. G. & Daher, E. F. Kidney involvement in leishmaniasis — a review. Braz. J. Infect. Dis. 18, 434–440 (2014).
pubmed: 24690431
doi: 10.1016/j.bjid.2013.11.013
McGwire, B. S. & Satoskar, A. R. Leishmaniasis: clinical syndromes and treatment. QJM 107, 7–14 (2014).
pubmed: 23744570
doi: 10.1093/qjmed/hct116
Meneses, G. C., Henn, G. A. L., Martins, A. M. C., Oliveira, M. J. C. & Daher, E. F. Visceral leishmaniasis (Kala-azar) nephropathy. in Tropical Nephrology (Bezerra da Silva Junior, G. B., De Francesco Daher, E. F. & Barros, E.) 249–262 (Springer Nature, 2020).
World Health Organization. Leishmaniasis: epidemiological situation. https://www.who.int/leishmaniasis/burden/en/ (2020).
Viriyavejakul, P., Viravan, C., Riganti, M. & Punpoowong, B. Imported cutaneous leishmaniasis in Thailand. Southeast Asian J. Trop. Med. Public Health 28, 558–562 (1997).
pubmed: 9561608
Leelayoova, S. et al. Leishmaniasis in Thailand: a review of causative agents and situations. Am. J. Trop. Med. Hyg. 96, 534–542 (2017).
pubmed: 28093539
pmcid: 5361524
Alcântara, C. C. S. et al. Renal dysfunction in leishmaniasis and Chagas disease coinfection: a case report. Rev. Inst. Med. Trop. S. Paulo 60, e73 (2018).
pubmed: 30462796
pmcid: 6235430
doi: 10.1590/s1678-9946201860073
Meneses, G. C. et al. Visceral leishmaniasis-associated nephropathy in hospitalized Brazilian patients: new insights based on kidney injury biomarkers. Trop. Med. Int. Health 23, 1046–1057 (2018).
pubmed: 29987885
doi: 10.1111/tmi.13127
Oliveira, M. J. C. et al. Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). Am. J. Trop. Med. Hyg. 82, 449–453 (2010).
pubmed: 20207871
pmcid: 2829907
doi: 10.4269/ajtmh.2010.09-0571
Hailu, W. et al. Acute kidney injury in patients with visceral leishmaniasis in Northwest Ethiopia. PLoS One 16, e 0252419 (2021).
doi: 10.1371/journal.pone.0252419
Oliveira, R. A. et al. Renal tubular dysfunction in patients with American cutaneous leishmaniasis. Kidney Int. 80, 1099–1106 (2011).
pubmed: 21814169
doi: 10.1038/ki.2011.251
Rocha, P. N. et al. Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury. Antimicrob. Agents Chemother. 59, 6913–6921 (2015).
pubmed: 26303800
pmcid: 4604365
doi: 10.1128/AAC.01079-15
Eichenberger, A. et al. A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure. BMC Infect. Dis. 17, 81 (2017).
pubmed: 28095796
pmcid: 5240427
doi: 10.1186/s12879-017-2192-4
Pedroso, J. A. et al. Elderly kidney transplant recipient with intermittent fever: a case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy. Transpl. Proc. 46, 2365–2367 (2014).
doi: 10.1016/j.transproceed.2014.07.064
Comai, G. et al. Screening strategies for the diagnosis of asymptomatic Leishmania infection in dialysis patients as a model for kidney transplant candidates. J. Nephrol. 34, 191–195 (2021).
pubmed: 32002798
doi: 10.1007/s40620-020-00705-4
Daher, E. F., Fonseca, P. P., Gerhard, E. S. & Silva Leitão, T. M. J. & Silva Junior, G.B. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil. J. Parasitol. 95, 652–655 (2009).
pubmed: 19642802
doi: 10.1645/GE-1678.1
Vassallo, M. et al. Visceral leishmaniasis due to Leishmania infantum with renal involvement in HIV-infected patients. BMC Infect. Dis. 14, 561 (2014).
pubmed: 25358548
pmcid: 4216653
doi: 10.1186/s12879-014-0561-9
Enríquez, R. et al. Membranoproliferative glomerulonephritis due to visceral leishmaniasis in an HIV patient. Am. J. Case. Rep. 9, 8–11 (2015).
doi: 10.1186/1752-1947-9-8
Santos, V. S. et al Malaria and renal complications. in Tropical Nephrology (Bezerra da Silva Junior, G. B., De Francesco Daher, E. F. & Barros, E.). 227–289 (Springer Nature, 2020).
Barber, B. E. et al. Intravascular haemolysis in severe Plasmodium knowlesi malaria: association with endothelial activation, microvascular dysfunction, and acute kidney injury. Emerg. Microbes Infect. 7, 106 (2018).
pubmed: 29872039
pmcid: 5988665
doi: 10.1038/s41426-018-0105-2
Grigg, M. J. E. et al. Age-related clinical spectrum of plasmodium knowlesi malaria and predictors of severity. Clin. Infect. Dis. 67, 350–359 (2018).
pubmed: 29873683
pmcid: 6051457
doi: 10.1093/cid/ciy065
Price, R. N., Douglas, N. M. & Anstey, N. M. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr. Opin. Infect. Dis. 2, 430–435 (2009).
doi: 10.1097/QCO.0b013e32832f14c1
Naing, C., Whittaker, M. A., Wai, V. N. & Mal, J. W. Is Plasmodium vivax malaria a severe malaria? A systematic review and meta-analysis. PLoS Negl. Trop. Dis. 8, e3071 (2014).
pubmed: 25121491
pmcid: 4133404
doi: 10.1371/journal.pntd.0003071
Howes, R. E. et al. Global epidemiology of Plasmodium vivax. Am. J. Trop. Med. Hyg. 95, 15–34 (2016).
pubmed: 27402513
pmcid: 5198891
doi: 10.4269/ajtmh.16-0141
World Health Organization. Malaria — Key Facts https://www.who.int/news-room/fact-sheets/detail/malaria (2022).
Batte, A. et al. Malaria-associated acute kidney injury in African children: prevalence, pathophysiology, impact, and management challenges. Int. J. Nephrol. Renovasc. Dis. 14, 235–253 (2021).
pubmed: 34267538
pmcid: 8276826
doi: 10.2147/IJNRD.S239157
Silva Junior, G. B., Pinto, J. R., Barros, E. J. G., Farias, G. M. N. & Daher, E. F. Kidney involvement in malaria: an update. Rev. Inst. Med. Trop. S. Paulo 59, e53 (2017).
Plewes, K. et al. Acetaminophen as a renoprotective adjunctive treatment in patients with severe and moderately severe falciparum malaria: a randomized, controlled, open-label trial. Clin. Infect. Dis. 67, 991–999 (2018).
pubmed: 29538635
pmcid: 6137116
doi: 10.1093/cid/ciy213
Kaur, C. et al. Renal detection of Plasmodium falciparum, Plasmodium vivax and Plasmodium knowlesi in malaria associated acute kidney injury: a retrospective case–control study. BMC Res. Notes 13, 37 (2020).
pubmed: 31959229
pmcid: 6971858
doi: 10.1186/s13104-020-4900-1
Koopmans, L. C. et al. Acute kidney injury in imported Plasmodium falciparum malaria. Malar. J. 14, 523 (2015).
pubmed: 26702815
pmcid: 4690233
doi: 10.1186/s12936-015-1057-9
Shukla, V. S., Singh, R. G. & Rathore, S. S. Usha. Outcome of malaria-associated acute kidney injury: a prospective study from a single center. Ren. Fail. 35, 801–805 (2013).
Prasad, R. & Mishra, O. P. Acute kidney injury in children with Plasmodium falciparum malaria: determinants for mortality. Perit. Dial. Int. 36, 213–217 (2016).
pubmed: 26429418
pmcid: 4803368
doi: 10.3747/pdi.2014.00254
Padhi, R. K. & Mishra, S. Incidence of renal involvement in malaria in children of Odisha. ISRN Nephrol. 2013, 573735 (2012).
pubmed: 24967228
pmcid: 4045417
Conroy, A. L. et al. Chitinase‑3‑like 1 is a biomarker of acute kidney injury and mortality in paediatric severe malaria. Malar. J. 17, 82 (2018).
pubmed: 29448936
pmcid: 5815237
doi: 10.1186/s12936-018-2225-5
Zaki, S. A. et al. Acute renal failure associated with malaria in children. Saudi. J. Kidney Dis. Transpl. 24, 303–308 (2013).
pubmed: 23538354
doi: 10.4103/1319-2442.109585
Rivera-Correa, J. et al. Autoantibody levels are associated with acute kidney injury, anemia and post-discharge morbidity and mortality in Ugandan children with severe malaria. Sci. Rep. 9, 14940 (2019).
pubmed: 31624288
pmcid: 6797715
doi: 10.1038/s41598-019-51426-z
Plewes, K. et al. Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study. BMC Infect. Dis. 17, 313 (2017).
pubmed: 28449641
pmcid: 5408414
doi: 10.1186/s12879-017-2373-1
Plewes, K. et al. Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria. Malar. J. 13, 91 (2014).
pubmed: 24618154
pmcid: 3995633
doi: 10.1186/1475-2875-13-91
Löwenberg, E. C. et al. Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13. Thromb. Haemost. 103, 181–187 (2010).
pubmed: 20062916
doi: 10.1160/TH09-04-0223
Barsoum, R. S. Parasitic kidney disease: milestones in the evolution of our knowledge. Am. J. Kidney Dis. 61, 501–513 (2013).
pubmed: 23337800
doi: 10.1053/j.ajkd.2012.09.025
Halleux, D. et al. A nephrotic syndrome of tropical origin: case report and short review of the aetiology. Acta Clin. Belg. 69, 379–381 (2014).
pubmed: 25103593
doi: 10.1179/2295333714Y.0000000057
Gentile, F. et al. From Uganda to Italy: a case of nephrotic syndrome secondary to Plasmodium infection, quartan malarial nephropathy and kidney failure. Turk. J. Pediatr. 61, 776–779 (2019).
pubmed: 32105012
doi: 10.24953/turkjped.2019.05.019
Azhar, M., Alasadi, L., Kemnele, S., Reiser, I. W. & Spitalewitz, S. Collapsing focal segmental glomerulosclerosis with acute interstitial nephritis associated with plasmodium falciparum: a case report and review of the literature. Am. J. Case. Rep. 20, 1576–1580 (2019).
pubmed: 31655844
pmcid: 6830302
doi: 10.12659/AJCR.917722
Bhadauria, D. et al. P. vivax malaria presenting as thrombotic microangiopathy. J. Assoc. Physicians India 65, 28–31 (2017).
pubmed: 29313573
Duarte, D. B., Daher, E. F., Pinheiro, M. E., Oliveira, M. J. Schistosomiasis mansoni-associated kidney disease. in Tropical Nephrology (Bezerra da Silva Junior, G. B., De Francesco Daher, E. F. & Barros, E.) 113–129 (Springer Nature, 2020).
World Health Organization. Schistosomiasis — Key Facts https://www.who.int/news-room/fact-sheets/detail/schistosomiasis#:~:text=Epidemiology,for%20schistosomiasis%20live%20in%20Africa (2020).
Srougi, V., Gallucci, F. P., Mattedi, R. L. & Srougi, M. Carcinosarcoma of the bladder following local schistosomiasis infection. BMJ Case Rep. 2017, bcr2016218642 (2017).
pubmed: 28325721
pmcid: 5372233
doi: 10.1136/bcr-2016-218642
Oranusi, C. K., Nwofor, A. M. E., Onyiaorah, I. V. & Ukah, C. O. Schistosomal stricture of the ureter-diagnostic dilemma. Niger. J. Clin. Pract. 14, 495–498 (2011).
pubmed: 22248959
doi: 10.4103/1119-3077.91765
Wang, Y. et al. Urethral stricture caused by schistosomiasis in a renal transplant recipient. Nephrology 17, 197–198 (2012).
pubmed: 22257154
doi: 10.1111/j.1440-1797.2011.01516.x
Antwi, A., Aboah, K. E. K. & Sarpong, C. K. G. The unacknowledged impact of urinary schistosomiasis in children: 5 cases from Kumari, Ghana. Ghana. Med. J. 48, 228–233 (2014).
pubmed: 25709140
pmcid: 4335430
doi: 10.4314/gmj.v48i4.11
Ghirardo, S., Trevisan, M., Galimberti, A. M. C., Pennesi, M. & Barbi, E. Young girl with intermittent hematuria. Ann. Emerg. Med. 74, e21–e22 (2019).
pubmed: 31445557
doi: 10.1016/j.annemergmed.2019.03.005
Souza, C. A. et al. Prevalence of urodynamic changes with risk for upper urinary tract damage in neuroschistosomiasis patients. Rev. Soc. Bras. Med. Trop. 52, e20180101 (2019).
pubmed: 30652786
doi: 10.1590/0037-8682-0101-2018
Duarte, D. B. et al. Acute kidney injury in schistosomiasis: a retrospective cohort of 60 patients in Brazil. J. Parasitol. 101, 244–247 (2015).
pubmed: 25393856
doi: 10.1645/13-361.1
Hanemann, A. L. P. et al. Monocyte chemotactic protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation. PLoS One 8, e80421 (2013).
pubmed: 24265821
pmcid: 3827226
doi: 10.1371/journal.pone.0080421
Duarte, D. B. et al. Renal function in hepatosplenic schistosomiasis–an assessment of renal tubular disorders. PLoS One 9, e115197 (2014).
pubmed: 25531759
pmcid: 4274079
doi: 10.1371/journal.pone.0115197
Neves, P. D. M. M. et al. Schistosomiasis-associated glomerulopathy: clinical aspects, pathological characteristics, and renal outcomes. Clin. Nephrol. 93, 251–261 (2020).
pubmed: 32228829
doi: 10.5414/CN110013
Rosinger, A. Y. et al. Schistosomiasis and hydration status: Schistosoma haematobium, but not Schistosoma mansoni increases urine specific gravity among rural Tanzanian women. Am. J. Phys. Anthropol. 166, 952–959 (2018).
pubmed: 29664990
pmcid: 6105421
doi: 10.1002/ajpa.23479
Duarte, D. B. et al. Aquaporin-2 and NKCC2 expression pattern in patients with hepatosplenic schistosomiasis. Trop. Med. Int. Health 25, 1140–1144 (2020).
pubmed: 32632995
doi: 10.1111/tmi.13461
Araújo, S. A. et al. The immunohistological profile of membranous nephropathy associated with chronic Schistosoma mansoni infection reveals a glomerulopathy with primary features. Kidney Int. 96, 793–794 (2019).
pubmed: 31445585
doi: 10.1016/j.kint.2019.05.024
Otoni, A. et al. Chemokine profile in the sera and urine of patients with schistosomal glomerulopathy. Am. J. Trop. Med. Hyg. 90, 48–53 (2014).
pubmed: 24189364
pmcid: 3886426
doi: 10.4269/ajtmh.13-0270
Sobh, M. et al. Schistosoma mansoni nephropathy in Syrian golden hamsters: effect of dose and duration of infection. Nephron 59, 121–130 (1991).
pubmed: 1944725
doi: 10.1159/000186531
Galvão, R. L. F. et al. Kidney injury biomarkers and parasitic loads of Schistosoma mansoni in a highly endemic area in northeastern Brazil. Acta Trop. 228, 106311 (2022).
pubmed: 35038425
doi: 10.1016/j.actatropica.2022.106311
Santos, W. L. C., Sweet, G. M. M., Bahiense-Oliveira, M. & Rocha, P. N. Schistosomal glomerulopathy and changes in the distribution of histological patterns of glomerular diseases in Bahia, Brazil. Mem. Inst. Oswaldo Cruz 106, 901–904 (2011).
doi: 10.1590/S0074-02762011000700017
Rodrigues, V. L. et al. Glomerulonephritis in schistosomiasis mansoni: a time to reappraise. Rev. Soc. Bras. Med. Trop. 43, 638–642 (2010).
pubmed: 21181014
doi: 10.1590/S0037-86822010000600007
Barsoum, R. S. Urinary schistosomiasis: review. J. Adv. Res. 4, 453–459 (2013).
pubmed: 25685452
doi: 10.1016/j.jare.2012.08.004
Neves, P. D. M. M. et al. Schistosoma mansoni and membranous nephropathy. Kidney Int. 89, 959 (2016).
pubmed: 26994579
doi: 10.1016/j.kint.2015.12.015
Gonçalves, F. O., Fontes, T. M. S. & Canuto, A. P. P. S. L. Schistosoma mansoni associated glomerulopathy with IgA mesangial deposits: case report. J. Bras. Nefrol. 39, 86–90 (2017).
pubmed: 28355401
doi: 10.5935/0101-2800.20170015